Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literature
Oluwaseyi Adeuyan(Columbia University), Alejandro A. Gru(University of Virginia), Jeffrey W. Craig(Rockefeller University), Werner Kempf(University Hospital of Zurich), Celine M. Schreidah(Columbia University), Christina Mitteldorf(European Organisation for Research and Treatment of Cancer), Erika Morsia(Marche Polytechnic University), Larisa J. Geskin(Columbia University Irving Medical Center), Alessandro Pileri(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Jose A. Plaza(The Ohio State University Wexner Medical Center)
Cited by 3
Related Papers
Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure
|Journal of the American College of Cardiology|2003|606
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Defining early mycosis fungoides
|Journal of the American Academy of Dermatology|2005|543
Thalassemia Syndromes
|Unknown|2009|475
Cytotoxic/natural killer cell cutaneous lymphomas
|Cancer|2003|273